Johnson & Johnson completes acquisition of Firefly Bio, lowering 2026 margin guidance by ~150 bps.

{
  "signal_id": "db32202e-62ed-494b-9446-82c91ca27e9c",
  "signal_type": "sec-8k",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-08-04T07:03:42.696+00:00",
  "company": {
    "name": "Johnson & Johnson",
    "domain": "jnj.com"
  },
  "data": {
    "detail": "The completed acquisition of Firefly Bio, combined with a new collaboration, will trigger post-merger integration and is projected to reduce 2026 adjusted pre-tax operating margin by approximately 150 basis points. This signals significant immediate investment and creates pressure to find operational efficiencies and manage integration costs across IT, HR, and R&D.",
    "metrics": {
      "pct": -1.5,
      "timeframe": "immediate",
      "pct_context": "Combined decrease in adjusted pre-tax operating margin for 2026 due to recent transactions.",
      "dollar_context": "The acquisition is expected to reduce 2026 adjusted EPS by $0.46 per share."
    },
    "summary": "Johnson & Johnson completes acquisition of Firefly Bio, lowering 2026 margin guidance by ~150 bps.",
    "excerpts": "On July 29, 2026, Johnson & Johnson (the “Company”) announced the completion of the acquisition of Firefly Bio, Inc. (“Firefly”)...",
    "relevance": 0.95,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000163/jnj-20260729.htm",
    "filing_date": "2026-07-29",
    "filing_year": 2026,
    "fiscal_year_end": "07/29",
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic",
    "vendors_mentioned": [
      "Firefly Bio, Inc."
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/db32202e-62ed-494b-9446-82c91ca27e9c \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"jnj.com","limit":20}'